Why the study?
Pulmonary embolism remains a common and potentially deadly disease requiring a multifactorial approach across diverse clinical scenarios.
This review summarizes the investigation and management of pulmonary embolism in specific clinical scenarios including pregnancy, COVID-19, recurrent disease, and chronic thromboembolic pulmonary hypertension.
May inform PE strategies in pregnancy, COVID-19, and CTEPH; leaves open need for prospective validation in these populations.
Pulmonary embolism remains a common and potentially deadly disease, despite advances in diagnostic imaging, treatment and prevention. Managing pulmonary embolism requires a multifactorial approach involving risk stratification, determining appropriate diagnostics and selecting individualised therapy. The first part of this article reviewed the pathophysiology, risk factors, clinical presentation, diagnostic evaluation and therapeutic management and early outpatient management of pulmonary embolism. This second part summarises pulmonary embolism in the setting of pregnancy, COVID-19, recurrent disease and chronic thromboembolic pulmonary hypertension.
No takes yet. Share an insight, caveat, or question.
Stolberg et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: